Scientists discover how a killer fungus attacks HIV patients

April 23, 2014

Researchers have discovered that a type of white blood cell carries a deadly fungus into the brains of HIV positive patients, causing meningitis which kills more than 600,000 people a year.

The discovery could lead to more effective ways of tackling the as it infects the human body.

Globally, 1.6 million people died of AIDS-related illnesses worldwide in 2012 according to the World Health Organisation.

Researchers at St George's, University of London and the University of Birmingham tested 65 strains of the fungus Cryptococcus which had been collected from HIV positive patients enrolled in clinical trials by the St George's group.

Their aim was to find out what leads certain patients to have higher amounts of the fungus in their – a key indicator of likelihood of death.

This new study shows that fungal strains that are more easily engulfed by , called macrophages, go on to cause a higher fungal burden in patients.

Although macrophages are usually protective in the human immune response to infection, in this case the macrophages engulf but are unable to kill the fungus which is then trafficked within them to the brain.

The higher the level of fungus in the brain and spinal fluid in patients, the greater the risk of dying among HIV positive patients with meningitis.

The findings raise the possibility of developing brand new therapies for HIV positive patients that could target macrophages to prevent them transporting the fungus around the body.

Dr Tihana Bicanic, a Senior Lecturer and Clinical Specialist in Infectious Diseases in the Institute for Infection and Immunity at St George's, University of London, said: "Cryptococcal meningitis is the most common and deadly cause of meningitis in patients with suppressed immune systems, particularly in HIV/AIDS.

"We currently only have three antifungal drugs to deploy against this fungus. Studies such as this one improve our understanding of the clever strategies the fungus uses to hide from our immune system and pave the way for identifying potential targets for new antifungals."

Robin May, Professor of Infectious Diseases at the University of Birmingham, said: "This appears to be a remarkable case of a pathogen "hijacking" our own immune system in order to spread around the body.

"By understanding more about the way they do this, we hope to ultimately be able to develop therapies that will help patient immune systems to destroy, rather than protect, the ."

Explore further: Breast cancer drug fights fungal disease

More information: "Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS." Park BJ, et al. AIDS. 2009 Feb 20;23(4):525-30. DOI: 10.1097/QAD.0b013e328322ffac.

"Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis." Wilber Sabiiti, et al. J Clin Invest. DOI: 10.1172/JCI72950.

Related Stories

Breast cancer drug fights fungal disease

February 11, 2014
Tamoxifen, a drug currently used to treat breast cancer, also kills a fungus that causes a deadly brain infection in immunocompromised patients. The findings, which could lead to new treatments for a disease that kills more ...

Gene makes some HIV-infected patients more at risk for fungal disease

August 27, 2013
HIV-infected people who carry a gene for a specific protein face a 20-fold greater risk of contracting cryptococcal disease, according to a study published in mBio, the online open-access journal of the American Society for ...

Recommended for you

Paris spotlight on latest in AIDS science

July 21, 2017
Some 6,000 HIV experts gather in Paris from Sunday to report advances in AIDS science as fading hopes of finding a cure push research into new fields.

Scientists elicit broadly neutralizing antibodies to HIV in calves

July 20, 2017
Scientists supported by the National Institutes of Health have achieved a significant step forward, eliciting broadly neutralizing antibodies (bNAbs) to HIV by immunizing calves. The findings offer insights for HIV vaccine ...

Heart toxin reveals new insights into HIV-1 integration in T cell genome

July 20, 2017
Human immunodeficiency virus (HIV)-1 may have evolved to integrate its genetic material into certain immune-cell-activating genes in humans, according to new research published in PLOS Pathogens.

Scientists capture first high-resolution image of key HIV protein transitional state

July 13, 2017
A new, three-dimensional snapshot of HIV demonstrates the radical structural transformations that enable the virus to recognize and infect host cells, according to a new study led by scientists at The Scripps Research Institute ...

Barrier to autoimmune disease may open door to HIV, study suggests

July 11, 2017
Researchers from the University of Colorado School of Medicine have discovered that a process that protects the body from autoimmune disease also prevents the immune system from generating antibodies that can neutralize the ...

Team tests best delivery mode for potential HIV vaccine

June 20, 2017
For decades, HIV has successfully evaded all efforts to create an effective vaccine but researchers at The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) are steadily inching ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.